Sakurasaku Plus
7097
Timee
215A
Wintest
6721
Heartseed
219A
Raksul
4384
JP Stock MarketDetailed Quotes
2370 Medinet
- 38
- -1-2.56%
20min DelayMarket Closed Dec 13 15:30 JST
10.05BMarket Cap-5.71P/E (Static)
40High38Low1.28MVolume40Open39Pre Close50.23MTurnover5752wk High0.53%Turnover Ratio264.52MShares3752wk Low-6.01EPS TTM9.22BFloat Cap13900Historical HighLossP/E (Static)242.58MShs Float33Historical Low-6.65EPS LYR5.13%Amplitude--Dividend TTM1.81P/B100Lot Size--Div YieldTTM
Medinet News
Medinet: Financial results briefing materials for the fiscal year ending 2024/9
Medinet: Convocation materials for the 29th Annual General Meeting of Shareholders for the fiscal year ending 2024/9 (matters not described in issuance documents)
Medinet: Notice of Convocation of the 29th Annual General Meeting of Shareholders for the fiscal year ending 2024/9
Medinet: Notice Concerning Election of Director Candidates and Audit & Supervisory Board Candidates
Medinet: Notice Concerning Decrease in Capital and Capital Reserve Amounts and Disposal of Surplus Funds
Medinet: Notice regarding the recording of non-operating income and extraordinary losses
Medinet: Summary of Financial Results 2024
Medinet: Summary of financial results for the fiscal year ending September 2024 [Japanese GAAP] (unconsolidated)
Medinet: Explanatory materials on business plans and growth potential
Medinet: (Changes in disclosure matters) Changes in the use of funds and planned expenditure periods relating to the issuance of stock acquisition rights through third-party allotment
Medinet: [Progress of disclosure matters] Decision to discontinue development of regenerative medicine products for the purpose of treating chronic heart failure
Medinet: (Changes in disclosure matters) Changes in the planned expenditure period relating to the issuance of stock acquisition rights through third-party allotment
Medinet: Notice regarding mass exercise and completion of exercise of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third party allotment
Medinet: Strategic partnership agreement signed with AGC for cell therapy CDMO business
Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third-party allotment
Medinet: Announcements of individual stocks regarding the recognition of non-operating revenue.
Medinet: Overview of Q3 2024 financial results.
Medinet: Third quarter financial report for the September 2024 period (Japanese standard) (non-consolidated)
Medinet: Started manufacturing outsourcing for a new specified cell processed product ("S-DSC") related to hair regeneration.
Medinet: (Progress of disclosure matters) Taiwanese regulatory authorities have approved the provision of γδT cell therapy at new medical institutions (progress of licensing agreement with Medigen Biotechnology Corp.)